MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-20-0007589
Sai Sreyas Pharmaceutical Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹16.62 Cr
▲ 27% YoY
Net loss · FY 2025
₹12.12 Cr
Net margin -72.9%
EBITDA · FY 2025
-₹5.86 Cr
EBITDA margin -35.3%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹8 Cr
Issued & subscribed
Open charges
₹29.75 Cr
Secured borrowings
Company age
16 yrs
Est. 2010
Employees · EPFO
66
Provident fund records
About Sai Sreyas Pharmaceutical Private Limited
Data last updated:
Sai Sreyas Pharmaceutical Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 11 May 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2010PTC068382. Its GSTIN is 37AAQCS4037A1ZE (Andhra Pradesh).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹8 Cr. It is led by directors including Saraswathi Bakireddy and Dileep Kumar Reddy Bakireddy.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.62 Cr, a growth of 27% compared to the previous year. For the same year it recorded a net loss of ₹12.12 Cr (net margin -72.9%) and EBITDA of -₹5.86 Cr (EBITDA margin -35.3%). Revenue has grown at a compounded annual rate (CAGR) of 327% over three years.
The company has about 66 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹29.75 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
Sai Sreyas Pharmaceutical Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0007589). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sspharma.com.
Company details
CIN U24232TG2010PTC068382
Registration Number 068382
Incorporation Date 11 May 2010
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-20-0007589
CIN history
Sai Sreyas Pharmaceutical has one previous CIN (Corporate Identification Number): U24232AP2010PTC068382. The current CIN is U24232TG2010PTC068382, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2010PTC068382 | Current |
| U24232AP2010PTC068382 | Previous |
Key People
Saraswathi Bakireddy Director Dileep Kumar Reddy Bakireddy Director Devereddy Vidna Reddy Director Recognitions & Rankings of Sai Sreyas Pharmaceutical
Contact details
Sai Sreyas Pharmaceutical Private Limited's registered office is in Hyderabad, Telangana. Its website is sspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address# 708 7th Floor Manjeera Trinity Corporate Jntu To Hi – Tech City Road 3rd Phase Kphb Colony, Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, API Manufacturers
To see the full contact details of Sai Sreyas Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Sai Sreyas Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sai Sreyas Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sai Sreyas Pharmaceutical Private Limited, buy the company report.
Financials of Sai Sreyas Pharmaceutical Private Limited
FY 2024 filings availableSai Sreyas Pharmaceutical Private Limited reported revenue of ₹16.62 Cr (up 27% YoY) for FY 2025.
Revenue · FY 2025
₹16.62 Cr ▲ 27%
Net loss · FY 2025
₹12.12 Cr margin -72.9%
EBITDA · FY 2025
-₹5.86 Cr margin -35.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 27%
3 years · compounded
▲ 327%
EBITDA CAGR growth
1 year
▼ 4%
3 years · compounded
▼ 230%
5 years · compounded
▼ 356%
Revenue has grown at a compounded annual rate (CAGR) of 327% over three years, including 27% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.86 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹12.12 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -35.3% | ||||
| Net Profit Margin | -72.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sai Sreyas Pharmaceutical Private Limited, buy the company report.
Board of directors of Sai Sreyas Pharmaceutical Private Limited
Sai Sreyas Pharmaceutical has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saraswathi Bakireddy Also directs: SJD Developers Private Limited, Hexaforce Solutions LLP, Divi Pharma Private Limited and 3 more | Director | 19 Jun 2019 | 7 Years 4 Months | Current |
| Dileep Kumar Reddy Bakireddy | Director | 21 Jan 2021 | 5 Years 9 Months | Current |
| Devereddy Vidna Reddy | Director | 15 Dec 2011 | 14 Years 10 Months | Current |
| Bakireddy Jayarami Reddy Also directs: SJD Developers Private Limited, Hexaforce Solutions LLP, Divi Pharma Private Limited and 3 more | Director | 17 Feb 2020 | 6 Years 8 Months | Current |
Peer comparison
Sai Sreyas Pharmaceutical Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cropel Lifesciences Private Limited | ₹16.99 Cr (FY 2024) | -22.0% | Kalol, Gujarat, India | |||
| Susaah Laboratories Private Limited | ₹16.82 Cr (FY 2025) | -49.0% | Secunderabad, Telangana, India | |||
| Sai Sreyas Pharmaceutical Private Limitedthis company | ₹16.62 Cr (FY 2025) | -₹12.12 Cr | -72.9% | 27.0% | 66 | Hyderabad, Telangana, India |
| Rchem Organics (Bangalore) Private Limited | ₹16.49 Cr (FY 2025) | 47.0% | Bangalore, Karnataka, India | |||
| Solana Life Sciences Private Limited | ₹16.49 Cr (FY 2024) | 18.0% | Dhar, Madhya Pradesh, India | |||
| M.N.Chemicals Limited | ₹16.13 Cr (FY 2025) | 23.0% | Bangalore, Karnataka, India | |||
| Palam Pharma Private Limited | ₹16.11 Cr (FY 2025) | 9.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Sai Sreyas Pharmaceutical Private Limited, buy the company report.
Auditor
Sai Sreyas Pharmaceutical Private Limited is audited by Veeranjaneyulu Ravuri for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Veeranjaneyulu Ravuri | FY 2023 | 228905 |
Shareholding
The shareholding of Sai Sreyas Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sai Sreyas Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹29.75 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Aug 2021 | 100471970 | State Bank of India | ₹29.75 Cr | Open |
To see the full charge records of Sai Sreyas Pharmaceutical Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Sai Sreyas Pharmaceutical Private Limited has 1 court case on record: 1 filed by Sai Sreyas Pharmaceutical. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
To see the full case history of Sai Sreyas Pharmaceutical Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sai Sreyas Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sai Sreyas Pharmaceutical Private Limited has a workforce of 66 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
66
Active EPFO establishments
1
Employee growth
8.2%
GST
Sai Sreyas Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAQCS4037A1ZE | Andhra Pradesh | Active | 02 Mar 2020 |
To see the full GST registrations and return filing status of Sai Sreyas Pharmaceutical Private Limited, buy the company report.
Recent activity
Sai Sreyas Pharmaceutical Private Limited has 7 board changes on record since 2011: 4 appointments and 3 cessations. The latest: Dileep Kumar Reddy Bakireddy was appointed as Director on 21 Jan 2021.
AGM
Sai Sreyas Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Sai Sreyas Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with State Bank Of India of Rs. 29.75 Cr registered on 09 Aug 2021 with Charge ID 100471970 was modified on 18 Apr 2022.
Charges
A charge with State Bank Of India amounted to Rs. 29.75 Cr with Charge ID 100471970 was registered on 09 Aug 2021.
Appointed
Dileep Kumar Reddy Bakireddy was appointed as Director.
Appointed
Bakireddy Jayarami Reddy was appointed as Director.
Ceased
Divya Bakireddy ceased to be Director.
Ceased
Kiran Kumar Reddy Jambapuram ceased to be Director.
Appointed
Saraswathi Bakireddy was appointed as Director.
Ceased
Devereddy Vidna Reddy ceased to be Additional Director.
Appointed
Devereddy Vidna Reddy was appointed as Director.
Incorporation
11 May 2010
Sai Sreyas Pharmaceutical Private Limited was registered on 11 May 2010 with Roc Hyderabad & aged 16 years 5 months as per MCA records.
Frequently asked questions
Sai Sreyas Pharmaceutical is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 11 May 2010 (16+ years old) and is registered under CIN U24232TG2010PTC068382.
Sai Sreyas Pharmaceutical has 4 current directors:
- Saraswathi Bakireddy - Director
- Dileep Kumar Reddy Bakireddy - Director
- Devereddy Vidna Reddy - Director
- Bakireddy Jayarami Reddy - Director
The latest financial statements of Sai Sreyas Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Sai Sreyas Pharmaceutical is 37AAQCS4037A1ZE, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Sai Sreyas Pharmaceutical is U24232TG2010PTC068382. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sai Sreyas Pharmaceutical has 1 court case on record: 1 filed by the company.
Sai Sreyas Pharmaceutical was incorporated on 11 May 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sai Sreyas Pharmaceutical by revenue are Cropel Lifesciences Private Limited, Susaah Laboratories Private Limited, Rchem Organics (Bangalore) Private Limited, Solana Life Sciences Private Limited, M.N.Chemicals Limited and 1 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dileep Kumar Reddy Bakireddy was appointed as Director on 21 Jan 2021. Bakireddy Jayarami Reddy was appointed as Director on 17 Feb 2020. Divya Bakireddy ceased to be Director on 20 Jun 2019. Sai Sreyas Pharmaceutical has 7 board changes on record in total.
Yes, Sai Sreyas Pharmaceutical is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-20-0007589).
Sai Sreyas Pharmaceutical can be reached through the website sspharma.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages